Trattamento della mature seborroica del cuoio capelluto con uno shampoo contenente ciclopiroxolamina 1%

Translated title of the contribution: Treatment of seborrheic eczema of the scalp with a ciclopiroxolamine 1% shampoo

M. Pazzaglia, E. Ghetti, F. Stacul, Antonella Tosti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. Seborrheic dermatitis of the scalp is characterized by scaly, reddish lesions. The aetiological role of Pityrosporum ovale (Malassezia furfur) in seborrheic dermatitis is now supported by results from several studies. Several shampoos and lotions have been developed and marketed as active against dandruff. Ciclopiroxolamine is a substituted pyridone antimycotic unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi and a varriety of Gram-positive and Gram-negative bacteria. The purpose of this study was to determine the therapeutic validity of ciclopiroxolamine 1% shampoo (Stiprox®) in patients with mild or moderate seborrheic dermatitis of the scalp. Methods. In this study, from January to May 1998, twenty-one patients with mild or moderate seborrheic dermatitis of the scalp (8 males and 13 females aged 15-63) were treated with ciclopiroxolamine 1% shampoo for 6 weeks. Results. Twenty of 21 patients with mild or moderate seborrheic dermatitis of the scalp were cured. No side- effects related to treatment were observed. Conclusions. Ciclopiroxolamine 1% shampoo showed in our trial a good therapeutic validity for patients with seborrheic dermatitis of the scalp. Ciclopiroxolamine 1% shampoo can be considered an effective and safe shampoo for the treatment of mild or moderate seborrheic dermatitis of the scalp.

Original languageItalian
Pages (from-to)247-251
Number of pages5
JournalGiornale Italiano di Dermatologia e Venereologia
Volume135
Issue number2
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

ciclopirox
Seborrheic Dermatitis
Eczema
Scalp
Malassezia
Therapeutics
Fungi
Dandruff
Pyridones
Arthrodermataceae
Actinobacteria
Gram-Negative Bacteria

Keywords

  • Dermatitis, seborrheic therapy
  • Pyridones administration and dosage
  • Pyridones, therapeutic use
  • Scalp dermatoses therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Trattamento della mature seborroica del cuoio capelluto con uno shampoo contenente ciclopiroxolamina 1%. / Pazzaglia, M.; Ghetti, E.; Stacul, F.; Tosti, Antonella.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 135, No. 2, 01.01.2000, p. 247-251.

Research output: Contribution to journalArticle

@article{dac70dc6750d497baa4f5db6006d3da7,
title = "Trattamento della mature seborroica del cuoio capelluto con uno shampoo contenente ciclopiroxolamina 1{\%}",
abstract = "Background. Seborrheic dermatitis of the scalp is characterized by scaly, reddish lesions. The aetiological role of Pityrosporum ovale (Malassezia furfur) in seborrheic dermatitis is now supported by results from several studies. Several shampoos and lotions have been developed and marketed as active against dandruff. Ciclopiroxolamine is a substituted pyridone antimycotic unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi and a varriety of Gram-positive and Gram-negative bacteria. The purpose of this study was to determine the therapeutic validity of ciclopiroxolamine 1{\%} shampoo (Stiprox{\circledR}) in patients with mild or moderate seborrheic dermatitis of the scalp. Methods. In this study, from January to May 1998, twenty-one patients with mild or moderate seborrheic dermatitis of the scalp (8 males and 13 females aged 15-63) were treated with ciclopiroxolamine 1{\%} shampoo for 6 weeks. Results. Twenty of 21 patients with mild or moderate seborrheic dermatitis of the scalp were cured. No side- effects related to treatment were observed. Conclusions. Ciclopiroxolamine 1{\%} shampoo showed in our trial a good therapeutic validity for patients with seborrheic dermatitis of the scalp. Ciclopiroxolamine 1{\%} shampoo can be considered an effective and safe shampoo for the treatment of mild or moderate seborrheic dermatitis of the scalp.",
keywords = "Dermatitis, seborrheic therapy, Pyridones administration and dosage, Pyridones, therapeutic use, Scalp dermatoses therapy",
author = "M. Pazzaglia and E. Ghetti and F. Stacul and Antonella Tosti",
year = "2000",
month = "1",
day = "1",
language = "Italian",
volume = "135",
pages = "247--251",
journal = "Giornale Italiano di Dermatologia e Venereologia",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Trattamento della mature seborroica del cuoio capelluto con uno shampoo contenente ciclopiroxolamina 1%

AU - Pazzaglia, M.

AU - Ghetti, E.

AU - Stacul, F.

AU - Tosti, Antonella

PY - 2000/1/1

Y1 - 2000/1/1

N2 - Background. Seborrheic dermatitis of the scalp is characterized by scaly, reddish lesions. The aetiological role of Pityrosporum ovale (Malassezia furfur) in seborrheic dermatitis is now supported by results from several studies. Several shampoos and lotions have been developed and marketed as active against dandruff. Ciclopiroxolamine is a substituted pyridone antimycotic unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi and a varriety of Gram-positive and Gram-negative bacteria. The purpose of this study was to determine the therapeutic validity of ciclopiroxolamine 1% shampoo (Stiprox®) in patients with mild or moderate seborrheic dermatitis of the scalp. Methods. In this study, from January to May 1998, twenty-one patients with mild or moderate seborrheic dermatitis of the scalp (8 males and 13 females aged 15-63) were treated with ciclopiroxolamine 1% shampoo for 6 weeks. Results. Twenty of 21 patients with mild or moderate seborrheic dermatitis of the scalp were cured. No side- effects related to treatment were observed. Conclusions. Ciclopiroxolamine 1% shampoo showed in our trial a good therapeutic validity for patients with seborrheic dermatitis of the scalp. Ciclopiroxolamine 1% shampoo can be considered an effective and safe shampoo for the treatment of mild or moderate seborrheic dermatitis of the scalp.

AB - Background. Seborrheic dermatitis of the scalp is characterized by scaly, reddish lesions. The aetiological role of Pityrosporum ovale (Malassezia furfur) in seborrheic dermatitis is now supported by results from several studies. Several shampoos and lotions have been developed and marketed as active against dandruff. Ciclopiroxolamine is a substituted pyridone antimycotic unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi and a varriety of Gram-positive and Gram-negative bacteria. The purpose of this study was to determine the therapeutic validity of ciclopiroxolamine 1% shampoo (Stiprox®) in patients with mild or moderate seborrheic dermatitis of the scalp. Methods. In this study, from January to May 1998, twenty-one patients with mild or moderate seborrheic dermatitis of the scalp (8 males and 13 females aged 15-63) were treated with ciclopiroxolamine 1% shampoo for 6 weeks. Results. Twenty of 21 patients with mild or moderate seborrheic dermatitis of the scalp were cured. No side- effects related to treatment were observed. Conclusions. Ciclopiroxolamine 1% shampoo showed in our trial a good therapeutic validity for patients with seborrheic dermatitis of the scalp. Ciclopiroxolamine 1% shampoo can be considered an effective and safe shampoo for the treatment of mild or moderate seborrheic dermatitis of the scalp.

KW - Dermatitis, seborrheic therapy

KW - Pyridones administration and dosage

KW - Pyridones, therapeutic use

KW - Scalp dermatoses therapy

UR - http://www.scopus.com/inward/record.url?scp=0033938506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033938506&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033938506

VL - 135

SP - 247

EP - 251

JO - Giornale Italiano di Dermatologia e Venereologia

JF - Giornale Italiano di Dermatologia e Venereologia

SN - 0392-0488

IS - 2

ER -